Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome
Authors:
- Roberta La PianaRPRoberta La Piana
- Carla UggettiCUCarla Uggetti
- Federico RoncaroloFederico Roncarolo
- Adeline VanderverAVAdeline Vanderver
- Ivana OlivieriIOIvana Olivieri
- Davide TondutiDTDavide Tonduti
- Guy HelmanGHGuy Helman
- Umberto BalottinUBUmberto Balottin
- Elisa FazziEFElisa Fazzi
- Yanick J. CrowYCYanick J. Crow
- John LivingstonJLJohn Livingston
- Simona OrcesiSOSimona Orcesi
- 5 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (1) , 28-35
Abstract
Objective: To perform an updated characterization of the neuroradiologic features of Aicardi-Goutières syndrome (AGS). Methods: The neuroradiologic data of 121 subjects with AGS were collected. The CT and MRI data were analyzed with a systematic approach. Moreover, we evaluated if an association exists between the neuroradiologic findings, clinical features, and genotype. Results: Brain calcifications were present in 110 subjects (90.9%). Severe calcification was associated with TREX1 mutations and early age at onset. Cerebral atrophy was documented in 111 subjects (91.8%). Leukoencephalopathy was present in 120 children (99.2%), with 3 main patterns: frontotemporal, diffuse, and periventricular. White matter rarefaction was found in 54 subjects (50.0%), strongly associated with mutations in TREX1 and an early age at onset. Other novel radiologic features were identified: deep white matter cysts, associated with TREX1 mutations, and delayed myelination, associated with RNASEH2B mutations and early age at onset. Conclusions: We demonstrate that the AGS neuroradiologic phenotype is expanding by adding new patterns and findings to the classic criteria. The heterogeneity of neuroradiologic patterns is partly explained by the timing of the disease onset and reflects the complexity of the pathogenic mechanisms.Keywords
This publication has 33 references indexed in Scilit:
- Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control studyThe Lancet Neurology, 2013
- Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patientLupus, 2013
- Cockayne syndrome: The expanding clinical and mutational spectrumMechanisms of Ageing and Development, 2013
- Recognizable phenotypes associated with intracranial calcificationDevelopmental Medicine & Child Neurology, 2012
- Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signatureNature Genetics, 2012
- Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset strokeProceedings of the National Academy of Sciences, 2011
- Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutières syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expressionHuman Mutation, 2010
- Neuroimaging In Cockayne SyndromeAmerican Journal of Neuroradiology, 2010
- Aicardi-Goutières Syndrome: Neuroradiologic Findings and Follow-UpAmerican Journal of Neuroradiology, 2009
- Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune responseNature Genetics, 2009